SOUTH SAN FRANCISCO, Calif., April 26, 2023 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO),…
Builds on recent preclinical data presented at AACR supporting the use of CCNE1 amplification and…
Builds on recent preclinical data presented at AACR supporting the use of CCNE1 amplification and…
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage…
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage…
MALVERN, Pa., April 26, 2023 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage…
MALVERN, Pa., April 26, 2023 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage…
AFM24-101 phase 1/2 interim results from the non-small cell lung cancer cohort accepted for poster…
AFM24-101 phase 1/2 interim results from the non-small cell lung cancer cohort accepted for poster…
Comprehensive Phase 1 data at ASCO support initiation of two Phase 2 trials REDWOOD CITY,…
Comprehensive Phase 1 data at ASCO support initiation of two Phase 2 trials REDWOOD CITY,…
Media Release Final results from Part C of the Phase II TACTI-002 trial in 2nd…
Media Release Final results from Part C of the Phase II TACTI-002 trial in 2nd…
New clinical data from registrational FIREFLY-1 study to be featured as an oral presentation Trial-in-progress…
AUSTIN, Texas, April 26, 2023 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage…
First wireless company in Canada to bring satellite connectivity to Canadians coast to coast Companies…
The platform empowers teams to build any custom conversational AI use case in minutes —…
London, United Kingdom–(Newsfile Corp. – April 26, 2023) – On March 13th, Dr. Jo R.S.,…
Burlington, Ontario–(Newsfile Corp. – April 26, 2023) – Evertz Technologies Limited (TSX: ET), a global…
Toronto, Ontario–(Newsfile Corp. – April 26, 2023) – DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB:…